Suvretta Capital Management, LLC Solid Biosciences Inc. Transaction History

Suvretta Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.51 - $7.56 $2.28 Million - $33.8 Million	-4,467,204 Reduced 88.16%	600,000 $4.2 Million
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $927,792 - $2.68 Million	-2,157,656 Reduced 29.86%	5,067,204 $3.12 Million
Q1 2022 May 16, 2022	BUY	$0.74 - $1.79 $693,873 - $1.68 Million	937,667 Added 14.91%	7,224,860 $8.67 Million
Q4 2021 Feb 14, 2022	BUY	$1.69 - $2.46 $528,970 - $769,980	313,000 Added 5.24%	6,287,193 $11 Million
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $10.3 Million - $20.6 Million	1,920,139 Added 47.36%	5,974,193 $33 Million
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $12.5 Million - $31.6 Million	4,054,054 New	4,054,054 $30.7 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $22.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.